Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Altimmune (ALT) over the last 17 years, with Q3 2025 value amounting to $845000.0.

  • Altimmune's Receivables - Net rose 9742.99% to $845000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $845000.0, marking a year-over-year increase of 9742.99%. This contributed to the annual value of $544000.0 for FY2024, which is 5103.51% down from last year.
  • According to the latest figures from Q3 2025, Altimmune's Receivables - Net is $845000.0, which was up 9742.99% from $321000.0 recorded in Q2 2025.
  • Over the past 5 years, Altimmune's Receivables - Net peaked at $4.8 million during Q1 2021, and registered a low of $136000.0 during Q2 2023.
  • Moreover, its 5-year median value for Receivables - Net was $429000.0 (2021), whereas its average is $958559.5.
  • In the last 5 years, Altimmune's Receivables - Net tumbled by 9598.04% in 2022 and then surged by 54219.65% in 2023.
  • Over the past 5 years, Altimmune's Receivables - Net (Quarter) stood at $429000.0 in 2021, then crashed by 59.67% to $173000.0 in 2022, then soared by 542.2% to $1.1 million in 2023, then crashed by 51.04% to $544000.0 in 2024, then surged by 55.33% to $845000.0 in 2025.
  • Its last three reported values are $845000.0 in Q3 2025, $321000.0 for Q2 2025, and $507000.0 during Q1 2025.